BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 37838333)

  • 41. Ethyl 2,4-dicarboethoxy pantothenate, a derivative of pantothenic acid, prevents cellular damage initiated by environmental pollutants through Nrf2 activation.
    Yokota M; Yahagi S; Masaki H
    J Dermatol Sci; 2018 Nov; 92(2):162-171. PubMed ID: 30219519
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Perillaldehyde Inhibits AHR Signaling and Activates NRF2 Antioxidant Pathway in Human Keratinocytes.
    Fuyuno Y; Uchi H; Yasumatsu M; Morino-Koga S; Tanaka Y; Mitoma C; Furue M
    Oxid Med Cell Longev; 2018; 2018():9524657. PubMed ID: 29643980
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Regulatory Mechanism of the IL-33-IL-37 Axis via Aryl Hydrocarbon Receptor in Atopic Dermatitis and Psoriasis.
    Tsuji G; Yamamura K; Kawamura K; Kido-Nakahara M; Ito T; Nakahara T
    Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834081
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antioxidants for Healthy Skin: The Emerging Role of Aryl Hydrocarbon Receptors and Nuclear Factor-Erythroid 2-Related Factor-2.
    Furue M; Uchi H; Mitoma C; Hashimoto-Hachiya A; Chiba T; Ito T; Nakahara T; Tsuji G
    Nutrients; 2017 Mar; 9(3):. PubMed ID: 28273792
    [TBL] [Abstract][Full Text] [Related]  

  • 45. VTAMA
    Gupta AK; Ravi SP; Vincent K; Abramovits W
    Skinmed; 2022; 20(4):298-300. PubMed ID: 35976021
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The opposite effect of tapinarof between IMQ and IL-23 induced psoriasis mouse models.
    Zhu X; Han R; Tian X; Hochgerner M; Li H; Wang J; Xia J
    Exp Dermatol; 2024 Jan; 33(1):e14862. PubMed ID: 37350230
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Renal toxicity through AhR, PXR, and Nrf2 signaling pathway activation of ochratoxin A-induced oxidative stress in kidney cells.
    Lee HJ; Pyo MC; Shin HS; Ryu D; Lee KW
    Food Chem Toxicol; 2018 Dec; 122():59-68. PubMed ID: 30291945
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Induction of a chloracne phenotype in an epidermal equivalent model by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) is dependent on aryl hydrocarbon receptor activation and is not reproduced by aryl hydrocarbon receptor knock down.
    Forrester AR; Elias MS; Woodward EL; Graham M; Williams FM; Reynolds NJ
    J Dermatol Sci; 2014 Jan; 73(1):10-22. PubMed ID: 24161567
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cannabidiol mediates epidermal terminal differentiation and redox homeostasis through aryl hydrocarbon receptor (AhR)-dependent signaling.
    Jang YS; Jeong S; Kim AR; Mok BR; Son SJ; Ryu JS; Son WS; Yun SK; Kang S; Kim HJ; Kim DH; Shin JU
    J Dermatol Sci; 2023 Feb; 109(2):61-70. PubMed ID: 36725458
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tapinarof Cream 1% for Extensive Plaque Psoriasis: A Maximal Use Trial on Safety, Tolerability, and Pharmacokinetics.
    Jett JE; McLaughlin M; Lee MS; Parish LC; DuBois J; Raoof TJ; Tabolt G; Wilson T; Somerville MC; DellaMaestra W; Piscitelli SC
    Am J Clin Dermatol; 2022 Jan; 23(1):83-91. PubMed ID: 34713415
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sulforaphane protects from myocardial ischemia-reperfusion damage through the balanced activation of Nrf2/AhR.
    Silva-Palacios A; Ostolga-Chavarría M; Sánchez-Garibay C; Rojas-Morales P; Galván-Arzate S; Buelna-Chontal M; Pavón N; Pedraza-Chaverrí J; Königsberg M; Zazueta C
    Free Radic Biol Med; 2019 Nov; 143():331-340. PubMed ID: 31422078
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Systemic Pharmacokinetics, Safety, and Preliminary Efficacy of Topical AhR Agonist Tapinarof: Results of a Phase 1 Study.
    Bissonnette R; Vasist LS; Bullman JN; Collingwood T; Chen G; Maeda-Chubachi T
    Clin Pharmacol Drug Dev; 2018 Jun; 7(5):524-531. PubMed ID: 29389078
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tapinarof-induced folliculitis: The paradigm of activation of the aryl hydrocarbon signaling pathway.
    Konstantinou MP; Jendoubi F; Hegazy S; Bouznad A; Tauber M; Bulai-Livideanu C; Paul C
    J Am Acad Dermatol; 2021 Jul; 85(1):e37-e38. PubMed ID: 33677000
    [No Abstract]   [Full Text] [Related]  

  • 54. The aryl hydrocarbon receptor AhR links atopic dermatitis and air pollution via induction of the neurotrophic factor artemin.
    Hidaka T; Ogawa E; Kobayashi EH; Suzuki T; Funayama R; Nagashima T; Fujimura T; Aiba S; Nakayama K; Okuyama R; Yamamoto M
    Nat Immunol; 2017 Jan; 18(1):64-73. PubMed ID: 27869817
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Aryl hydrocarbon receptor activation restores filaggrin expression via OVOL1 in atopic dermatitis.
    Tsuji G; Hashimoto-Hachiya A; Kiyomatsu-Oda M; Takemura M; Ohno F; Ito T; Morino-Koga S; Mitoma C; Nakahara T; Uchi H; Furue M
    Cell Death Dis; 2017 Jul; 8(7):e2931. PubMed ID: 28703805
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A Review of Tapinarof: Novel Topical Treatment for Plaque Psoriasis in Adults.
    Kalabalik-Hoganson J; Nogid A; Frey K
    J Drugs Dermatol; 2023 Aug; 22(8):761-765. PubMed ID: 37556516
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The aryl hydrocarbon receptor interacts with nuclear factor erythroid 2-related factor 2 to mediate induction of NAD(P)H:quinoneoxidoreductase 1 by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    Wang L; He X; Szklarz GD; Bi Y; Rojanasakul Y; Ma Q
    Arch Biochem Biophys; 2013 Sep; 537(1):31-8. PubMed ID: 23800876
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tapinarof, a Novel, First-in-Class, Topical Therapeutic Aryl Hydrocarbon Receptor Agonist for the Management of Psoriasis.
    Bobonich M; Gorelick J; Aldredge L; Bruno MJ; DiRuggiero D; Martin G; Tallman AM; Gold LS
    J Drugs Dermatol; 2023 Aug; 22(8):779-784. PubMed ID: 37556512
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Luteolin modulates expression of drug-metabolizing enzymes through the AhR and Nrf2 pathways in hepatic cells.
    Zhang T; Kimura Y; Jiang S; Harada K; Yamashita Y; Ashida H
    Arch Biochem Biophys; 2014 Sep; 557():36-46. PubMed ID: 24914470
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Methylated pentavalent arsenic metabolites are bifunctional inducers, as they induce cytochrome P450 1A1 and NAD(P)H:quinone oxidoreductase through AhR- and Nrf2-dependent mechanisms.
    Anwar-Mohamed A; Elshenawy OH; Soshilov AA; Denison MS; Chris Le X; Klotz LO; El-Kadi AO
    Free Radic Biol Med; 2014 Feb; 67():171-87. PubMed ID: 24161444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.